PDUFA VII Negotiations Completed, Commitment Letter Ratification Ongoing
Executive Summary
The US FDA, HHS and White House, as well as industry groups, now must sign off on the document.
You may also be interested in...
Bending PDUFA’s Cost Curve: PhRMA Looking For Sustainable Program Growth
Industry feels that sufficient program management tools are in place, but a PDUFA VII negotiator says they need more time to mature.
PDUFA VII Commitment Letter Outlines Real-Time Review Expansion, Hiring Goals
Allergenic extract products, previously excluded, also will become part of the user fee program beginning in FY 2023.
US GDUFA III Talks In Final Stages, Agreement Nearly Complete
Final commitment letter preparations now under way as revenue issues are resolved.